The pathogenic form of HCC is manifested by the Leu68Gln mutation, where a hydrophobic amino acid residue is replaced by polar and bulkier one in the hydrophobic core of HCC, which results in development of serious disease—hereditary cystatin C amyloid angiopathy (HCCAA)24. The gene discussed is CST3; the disease is hepatocellular carcinoma.